![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: HKR1 |
Gene summary for HKR1 |
![]() |
Gene information | Species | Human | Gene symbol | HKR1 | Gene ID | 284459 |
Gene name | zinc finger protein 875 | |
Gene Alias | HKR1 | |
Cytomap | 19q13.12 | |
Gene Type | protein-coding | GO ID | GO:0000122 | UniProtAcc | K7EPW3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
284459 | HKR1 | AEH-subject1 | Human | Endometrium | AEH | 7.85e-04 | -1.32e-01 | -0.3059 |
284459 | HKR1 | AEH-subject2 | Human | Endometrium | AEH | 6.38e-09 | -1.32e-01 | -0.2525 |
284459 | HKR1 | AEH-subject3 | Human | Endometrium | AEH | 3.51e-03 | -1.32e-01 | -0.2576 |
284459 | HKR1 | AEH-subject4 | Human | Endometrium | AEH | 2.33e-06 | -1.32e-01 | -0.2657 |
284459 | HKR1 | AEH-subject5 | Human | Endometrium | AEH | 3.51e-03 | -1.32e-01 | -0.2953 |
284459 | HKR1 | EEC-subject1 | Human | Endometrium | EEC | 1.75e-04 | -1.32e-01 | -0.2682 |
284459 | HKR1 | EEC-subject2 | Human | Endometrium | EEC | 1.66e-03 | -1.32e-01 | -0.2607 |
284459 | HKR1 | EEC-subject3 | Human | Endometrium | EEC | 8.23e-05 | -1.32e-01 | -0.2525 |
284459 | HKR1 | EEC-subject4 | Human | Endometrium | EEC | 3.71e-04 | -1.32e-01 | -0.2571 |
284459 | HKR1 | EEC-subject5 | Human | Endometrium | EEC | 7.40e-03 | -1.32e-01 | -0.249 |
284459 | HKR1 | GSM6177620_NYU_UCEC1_lib1_lib1 | Human | Endometrium | EEC | 2.97e-05 | -4.29e-02 | -0.1869 |
284459 | HKR1 | GSM6177620_NYU_UCEC1_lib2_lib2 | Human | Endometrium | EEC | 2.47e-08 | -2.66e-02 | -0.1875 |
284459 | HKR1 | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 1.64e-06 | -1.18e-01 | -0.1883 |
284459 | HKR1 | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 3.21e-03 | -8.01e-02 | -0.1917 |
284459 | HKR1 | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 3.35e-10 | -3.99e-02 | -0.1916 |
284459 | HKR1 | PTC01 | Human | Thyroid | PTC | 5.73e-04 | 8.78e-02 | 0.1899 |
284459 | HKR1 | PTC03 | Human | Thyroid | PTC | 3.21e-04 | 1.34e-01 | 0.1784 |
284459 | HKR1 | PTC04 | Human | Thyroid | PTC | 3.20e-11 | 1.77e-01 | 0.1927 |
284459 | HKR1 | PTC05 | Human | Thyroid | PTC | 1.21e-06 | 3.26e-01 | 0.2065 |
284459 | HKR1 | PTC06 | Human | Thyroid | PTC | 4.63e-15 | 2.90e-01 | 0.2057 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
HKR1 | CD8TEFF | Breast | DCIS | CCR4,AC013264.1,LIMK1, etc. | 1.12e-01 | ![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
HKR1 | SNV | Missense_Mutation | novel | c.1897N>G | p.Lys633Glu | p.K633E | P10072 | protein_coding | deleterious(0.02) | probably_damaging(0.987) | TCGA-FI-A2D0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
HKR1 | SNV | Missense_Mutation | novel | c.856N>C | p.Ser286Pro | p.S286P | P10072 | protein_coding | deleterious(0.05) | benign(0.214) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD |
HKR1 | SNV | Missense_Mutation | novel | c.1148N>C | p.Lys383Thr | p.K383T | P10072 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD |
HKR1 | insertion | Nonsense_Mutation | novel | c.137_138insTAAAAAAGACCTATGAATAGTTCTCTCTCT | p.Glu46delinsAspLysLysAspLeuTerIleValLeuSerLeu | p.E46delinsDKKDL*IVLSL | P10072 | protein_coding | TCGA-D1-A0ZU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | SD | ||
HKR1 | SNV | Missense_Mutation | novel | c.1328G>T | p.Cys443Phe | p.C443F | P10072 | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-DD-A73C-01 | Liver | liver hepatocellular carcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
HKR1 | SNV | Missense_Mutation | novel | c.679N>G | p.Leu227Val | p.L227V | P10072 | protein_coding | tolerated(0.5) | benign(0.035) | TCGA-DD-AACF-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
HKR1 | SNV | Missense_Mutation | rs767652525 | c.932N>T | p.Thr311Met | p.T311M | P10072 | protein_coding | tolerated(0.2) | probably_damaging(0.931) | TCGA-DD-AACF-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
HKR1 | SNV | Missense_Mutation | c.1673G>T | p.Cys558Phe | p.C558F | P10072 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-05-4403-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
HKR1 | SNV | Missense_Mutation | novel | c.1562N>T | p.Gly521Val | p.G521V | P10072 | protein_coding | deleterious(0.02) | probably_damaging(0.977) | TCGA-50-5941-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Unspecific | Cisplatin | Complete Response |
HKR1 | SNV | Missense_Mutation | novel | c.1289N>A | p.Arg430Lys | p.R430K | P10072 | protein_coding | tolerated(0.64) | benign(0.012) | TCGA-55-8207-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |